Biotin-PEG6-Thalidomide is a heterobifunctional PROTAC linker in which a thalidomide cereblon-recruiting ligand is connected through a polyethylene glycol spacer to a biotin handle. Structurally, it contains a flexible PEG chain of moderate length that serves as a solubilizing, distance-defining element, while the biotin moiety enables strong, specific capture or immobilization on streptavidin/avidin surfaces for assay development or workflow integration. In PROTAC design, the thalidomide portion engages the E3 ubiquitin ligase substrate receptor cereblon, positioning the conjugated partner for ubiquitination and subsequent proteasomal degradation. The PEG spacer helps mitigate steric hindrance and can improve productive ternary complex formation, whereas the biotin tag facilitates tethering to solid supports, affinity enrichment, or surface-based readouts. This reagent is valuable for targeted protein degradation research requiring robust immobilization, controlled conjugation strategies, and improved experimental throughput in mechanistic and screening studies.
Structure of 2144775-48-2
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| ConcentrationVolumeMass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.2628 mL | 6.3138 mL | 12.6277 mL |
| 5 mM | 0.2526 mL | 1.2628 mL | 2.5255 mL |
| 10 mM | 0.1263 mL | 0.6314 mL | 1.2628 mL |
Biotin-PEG6-Thalidomide is a bifunctional PROTAC linker component designed to couple a biotin-based handle to a cereblon-recruiting thalidomide moiety through a flexible polyethylene glycol spacer. Its PEG architecture supports productive ternary complex formation by improving solubility and conformational adaptability, while the biotin functionality enables affinity-based detection or enrichment workflows. The molecule is therefore well suited for constructing targeted protein degradation systems; detailed structural and synthetic considerations follow below.
Structure: The linker comprises a polyethylene glycol chain that provides a flexible, hydrophilic scaffold, connecting a biotin-derived binding motif to a thalidomide-derived cereblon ligand. It contains amide and ether linkages typical of PEG-based conjugates, enabling stable covalent connectivity and favorable aqueous compatibility.
Reactivity: This component is used as a prefunctionalized PROTAC building block in conjugation strategies that preserve the cereblon-binding pharmacophore. Suitable assembly commonly relies on chemoselective coupling of the biotin end to complementary handles (e.g., activated esters or maleimides) under mild aqueous or mixed-solvent conditions, with reaction monitoring to avoid degradation of the thalidomide motif and to maintain linker integrity.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.